Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Cmss1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CMSS1 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Cmss1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CMSS1 mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CMSS1 mRNA | CTD | PMID:33387578 and PMID:34747641 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CMSS1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CMSS1 mRNA | CTD | PMID:28628672 | 4-phenylbutyric acid | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | 4-phenylbutyric acid results in decreased expression of CMSS1 mRNA | CTD | PMID:14583596 | aflatoxin B1 | affects expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of CMSS1 protein | CTD | PMID:20106945 | aflatoxin B1 | decreases methylation | ISO | CMSS1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of CMSS1 gene | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of CMSS1 mRNA | CTD | PMID:21632981 more ... | all-trans-retinoic acid | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CMSS1 mRNA | CTD | PMID:33167477 | amosite asbestos | decreases expression | ISO | Cmss1 (Mus musculus) | 6480464 | Asbestos and Amosite results in decreased expression of CMSS1 mRNA | CTD | PMID:23917077 | aristolochic acid A | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CMSS1 mRNA and aristolochic acid I results in decreased expression of CMSS1 protein | CTD | PMID:33212167 | arsane | affects methylation | ISO | CMSS1 (Homo sapiens) | 6480464 | Arsenic affects the methylation of CMSS1 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | CMSS1 (Homo sapiens) | 6480464 | Arsenic affects the methylation of CMSS1 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to CMSS1 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of CMSS1 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene diol epoxide I | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 and PMID:26238291 | bis(2-chloroethyl) sulfide | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Mustard Gas results in decreased expression of CMSS1 mRNA | CTD | PMID:25102026 | bisphenol A | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of CMSS1 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CMSS1 mRNA | CTD | PMID:28628672 and PMID:31601247 | bisphenol A | increases methylation | ISO | CMSS1 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of CMSS1 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CMSS1 mRNA | CTD | PMID:34947998 | bisphenol A | affects expression | ISO | CMSS1 (Homo sapiens) | 6480464 | bisphenol A affects the expression of CMSS1 mRNA | CTD | PMID:30903817 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of CMSS1 gene | CTD | PMID:28505145 | bisphenol F | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CMSS1 mRNA | CTD | PMID:28628672 | cadmium dichloride | decreases expression | ISO | Cmss1 (Mus musculus) | 6480464 | Cadmium Chloride results in decreased expression of CMSS1 mRNA | CTD | PMID:24982889 | calcitriol | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of CMSS1 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CMSS1 mRNA | CTD | PMID:21592394 | cantharidin | decreases expression | ISO | Cmss1 (Mus musculus) | 6480464 | Cantharidin results in decreased expression of CMSS1 mRNA | CTD | PMID:36907384 | chlorpyrifos | decreases expression | ISO | Cmss1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CMSS1 mRNA | CTD | PMID:37019170 | chromium(6+) | affects expression | ISO | Cmss1 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of CMSS1 mRNA | CTD | PMID:28472532 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CMSS1 mRNA | CTD | PMID:22023808 | cisplatin | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of CMSS1 mRNA | CTD | PMID:27392435 | cisplatin | increases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of CMSS1 mRNA | CTD | PMID:19561079 | clobetasol | increases expression | ISO | Cmss1 (Mus musculus) | 6480464 | Clobetasol results in increased expression of CMSS1 mRNA | CTD | PMID:27462272 | clofibrate | increases expression | ISO | Cmss1 (Mus musculus) | 6480464 | Clofibrate results in increased expression of CMSS1 mRNA | CTD | PMID:23811191 | coumestrol | increases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of CMSS1 mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CMSS1 mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of CMSS1 mRNA | CTD | PMID:20106945 more ... | cyclosporin A | decreases methylation | ISO | CMSS1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased methylation of CMSS1 promoter | CTD | PMID:27989131 | deguelin | increases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | deguelin results in increased expression of CMSS1 mRNA | CTD | PMID:33512557 | dexamethasone | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CMSS1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CMSS1 mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CMSS1 mRNA | CTD | PMID:21266533 | dicrotophos | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CMSS1 mRNA | CTD | PMID:28302478 | diethylstilbestrol | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Diethylstilbestrol results in decreased expression of CMSS1 mRNA | CTD | PMID:36621641 | ethanol | increases expression | ISO | Cmss1 (Mus musculus) | 6480464 | Ethanol results in increased expression of CMSS1 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of CMSS1 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | Cmss1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CMSS1 mRNA | CTD | PMID:22206623 | formaldehyde | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of CMSS1 mRNA | CTD | PMID:23649840 | fulvestrant | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of CMSS1 gene | CTD | PMID:31601247 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of CMSS1 mRNA | CTD | PMID:25539665 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of CMSS1 mRNA | CTD | PMID:33387578 | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of CMSS1 protein | CTD | PMID:23178681 | indometacin | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CMSS1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CMSS1 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CMSS1 protein | CTD | PMID:32959892 | methyl methanesulfonate | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of CMSS1 mRNA | CTD | PMID:23649840 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CMSS1 mRNA | CTD | PMID:28801915 | N-Nitrosopyrrolidine | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of CMSS1 mRNA | CTD | PMID:32234424 | O-methyleugenol | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of CMSS1 mRNA | CTD | PMID:32234424 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CMSS1 mRNA | CTD | PMID:25729387 | perfluorononanoic acid | increases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of CMSS1 mRNA | CTD | PMID:32588087 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cmss1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CMSS1 mRNA | CTD | PMID:36331819 | resveratrol | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CMSS1 mRNA | CTD | PMID:19167446 | rotenone | increases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Rotenone results in increased expression of CMSS1 mRNA | CTD | PMID:33512557 | serpentine asbestos | affects methylation | ISO | CMSS1 (Homo sapiens) | 6480464 | Asbestos and Serpentine affects the methylation of CMSS1 gene | CTD | PMID:29523930 | sunitinib | increases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of CMSS1 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | ISO | CMSS1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CMSS1 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of CMSS1 mRNA | CTD | PMID:21592394 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of CMSS1 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CMSS1 mRNA | CTD | PMID:25729387 | tungsten | increases expression | ISO | Cmss1 (Mus musculus) | 6480464 | Tungsten results in increased expression of CMSS1 mRNA | CTD | PMID:30912803 | tunicamycin | increases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of CMSS1 mRNA | CTD | PMID:29453283 | valproic acid | increases expression | ISO | CMSS1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CMSS1 mRNA | CTD | PMID:29154799 | |